BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19638648)

  • 1. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2549. PubMed ID: 19638648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2548. PubMed ID: 19638647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
    Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
    Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.
    Cotton S; Sharp L; Little J; Cruickshank M; Seth R; Smart L; Duncan I; Harrild K; Neal K; Waugh N;
    BJOG; 2010 May; 117(6):645-59. PubMed ID: 20374607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of human papillomavirus triage, repeat cytology, and immediate colposcopy in management of women with minor cytological abnormalities in Sweden.
    Ostensson E; Fröberg M; Hjerpe A; Zethraeus N; Andersson S
    Acta Obstet Gynecol Scand; 2010 Oct; 89(10):1316-25. PubMed ID: 20846064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of women with low grade cytology: how reassuring is a normal colposcopy examination?
    Cruickshank ME; Cotton SC; Sharp L; Smart L; Walker LG; Little J;
    BJOG; 2015 Feb; 122(3):380-6. PubMed ID: 24947656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
    Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.
    Kim JJ; Wright TC; Goldie SJ
    JAMA; 2002 May; 287(18):2382-90. PubMed ID: 11988059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-benefit analysis of colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear.
    Chesebro MJ; Everett WD
    Arch Fam Med; 1996; 5(10):576-81. PubMed ID: 8930229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).
    Kulasingam SL; Kim JJ; Lawrence WF; Mandelblatt JS; Myers ER; Schiffman M; Solomon D; Goldie SJ;
    J Natl Cancer Inst; 2006 Jan; 98(2):92-100. PubMed ID: 16418511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness.
    Melnikow J; Kulasingam S; Slee C; Helms LJ; Kuppermann M; Birch S; McGahan CE; Coldman A; Chan BK; Sawaya GF
    Obstet Gynecol; 2010 Nov; 116(5):1158-70. PubMed ID: 20966702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the cost-effectiveness and capacity impact of changes to colposcopy referral guidelines for women with mild dyskaryosis in the UK Cervical Screening Programme.
    Hadwin R; Eggington S; Brennan A; Walker P; Patnick J; Pilgrim H
    BJOG; 2008 May; 115(6):749-57. PubMed ID: 18410660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): Trial design.
    Cotton SC; Sharp L; Little J; Duncan I; Alexander L; Cruickshank ME; Gray NM; Jenkins D; Philips Z; Robertson A; Seth R;
    Contemp Clin Trials; 2006 Oct; 27(5):449-71. PubMed ID: 16765101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and effectiveness comparison of immediate colposcopy versus human papillomavirus DNA testing in management of atypical squamous cells of undetermined significance in Turkish women.
    Kececioglu M; Seckin B; Baser E; Togrul C; Kececioglu TS; Cicek MN; Gungor T
    Asian Pac J Cancer Prev; 2013; 14(1):511-4. PubMed ID: 23534785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation.
    Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Howard M; Roth P; Lorincz AT; Gafni A; Walter SD
    Arch Pathol Lab Med; 2003 Sep; 127(9):1169-75. PubMed ID: 12946228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.